Alzheimer disease is the leading cause of dementia in the elderly, affecting more than 4 million individuals in the U.S. alone. A genetic component has long been indicated in the etiology of the disease and has been supported in a number of genetic and epidemiological studies. Although some families show clear evidence of autosomal dominant inheritance, many others are equivocal, and thus the mode of inheritance of familial Alzheimer disease (FAD) is not well established. One gene for FAD has been identified (APP), but it accounts for less than 2% of FAD cases, and no other genes have yet been identified, although a location on chromosome 19 has been proposed. Through the efforts of the Human Genome Initiative, it is now possible to efficiently screen the entire genome for genes associated with FAD. The goal of the present proposal is to perform an efficient screen of the entire genome in order to identify all the major loci involved in FAD. Both early and late onset families will be incorporated into the screening process. A multicenter approach will be used to rapidly generate the necessary marker data, and to rapidly and efficiently perform the statistical analyses on these data. Since the emphasis of this proposal is on the analysis of the resulting data, only well-defined marker systems will be used and no effort will be expended to generate new markers. This approach will allow us to fully exploit the efforts of the Human Genome Initiative, thereby helping to fulfill its promise. A hierarchical structure for genotyping of the families will be established. Initially, a core set of families will be identified that have sufficient power to generate significant standard linkage results. Additional pedigrees with only a few affected individuals will be used for a variety of state of the art statistical methodologies including affected-pedigree-member (APM) analysis, sib-pair linkage studies as well as maximum likelihood methods inclusive of two locus models. Examination for and effects of heterogeneity and age of onset will also be incorporated into the study. The ultimate goal of the proposed research is the identification of all major loci involved in FAD etiology, as the first step in combatting this devastating disorder of the elderly.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
1R01NS031153-01
Application #
3418085
Study Section
Genome Study Section (GNM)
Project Start
1993-01-01
Project End
1996-12-31
Budget Start
1993-01-01
Budget End
1993-12-31
Support Year
1
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Duke University
Department
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Lambert, Jean-Charles; Sleegers, Kristel; González-Pérez, Antonio et al. (2010) The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study. J Alzheimers Dis 22:247-55
Beecham, Gary W; Naj, Adam C; Gilbert, John R et al. (2010) PCDH11X variation is not associated with late-onset Alzheimer disease susceptibility. Psychiatr Genet 20:321-4
Beecham, Gary W; Martin, Eden R; Gilbert, John R et al. (2010) APOE is not associated with Alzheimer disease: a cautionary tale of genotype imputation. Ann Hum Genet 74:189-94
Naj, Adam C; Beecham, Gary W; Martin, Eden R et al. (2010) Dementia revealed: novel chromosome 6 locus for late-onset Alzheimer disease provides genetic evidence for folate-pathway abnormalities. PLoS Genet 6:e1001130
Beecham, Gary W; Martin, Eden R; Li, Yi-Ju et al. (2009) Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease. Am J Hum Genet 84:35-43
Slifer, Michael A; Martin, Eden R; Gilbert, John R et al. (2009) Resolving the relationship between ApolipoproteinE and depression. Neurosci Lett 455:116-9
Beecham, Gary W; Schnetz-Boutaud, Nathalie; Haines, Jonathan L et al. (2009) CALHM1 polymorphism is not associated with late-onset Alzheimer disease. Ann Hum Genet 73:379-81
Xu, Pu-Ting; Li, Yi-Ju; Qin, Xue-Jun et al. (2007) A SAGE study of apolipoprotein E3/3, E3/4 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease. Mol Cell Neurosci 36:313-31
Xu, Pu-Ting; Li, Yi-Ju; Qin, Xue-Jun et al. (2006) Differences in apolipoprotein E3/3 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease. Neurobiol Dis 21:256-75
Ercoli, Linda; Siddarth, Prabha; Huang, Sung-Cheng et al. (2006) Perceived loss of memory ability and cerebral metabolic decline in persons with the apolipoprotein E-IV genetic risk for Alzheimer disease. Arch Gen Psychiatry 63:442-8

Showing the most recent 10 out of 47 publications